Gulden Menderes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Gulden Menderes has a total of 84 co-authors. Here are the top co-authors by number of shared publications:
- Joan Tymon-Rosario
Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale University School of Medicine, New Haven, CT 06520, USA
8 shared publications - Masoud Azodi
Yale School of Medicine, Department of Obstetrics, Gynecology & Reproductive Sciences
6 shared publications - Alessandro Davide Santin
Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, CT 06520, USA
5 shared publications Masoud Azodi
Department of Obstetrics and Gynecology, Yale New Haven Health - Bridgeport Hospital, Bridgeport, CT, USA
5 shared publications- Peter E. Schwartz
Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, CT 06510
5 shared publications - Elena Ratner
Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale University School of Medicine, New Haven, Connecticut
4 shared publications
Latest Publications
- 24 May 2022
- Published by Taylor & Francis in Expert Review of Anticancer Therapy
- Vol. 22 (6) , 633-645
Targeted treatment options for the management of metastatic/persistent and recurrent cervical cancer
Cervical cancer is the overall fourth most common malignancy and the fourth most common cause of cancer related deaths worldwide. Despite vaccination and screening programs, many women continue to ...
- 24 May 2022
- Published by Taylor & Francis in Expert Review of Anticancer Therapy
- Vol. 22 (6) , 633-645
Targeted treatment options for the management of metastatic/persistent and recurrent cervical cancer
Cervical cancer is the overall fourth most common malignancy and the fourth most common cause of cancer related deaths worldwide. Despite vaccination and screening programs, many women continue to ...
- Open Access
- 16 March 2022
- Published by Elsevier in Gynecologic Oncology Reports
- Vol. 40, 100959
Robotic interval debulking with radical hysterectomy and partial urinary bladder resection for locally advanced carcinosarcoma of the uterus
- 16 March 2022
- Published by Elsevier in Gynecologic Oncology Reports
- Vol. 40, 100959
Open AccessRobotic interval debulking with radical hysterectomy and partial urinary bladder resection for locally advanced carcinosarcoma of the uterus
- Open Access
- 1 January 2022
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 33 (2) , e13
An evaluation of prognostic factors, oncologic outcomes, and management for primary and recurrent squamous cell carcinoma of the vulva
Li JY, et al. J Gynecol Oncol. 2021 Nov;33:e13. https://doi.org/10.3802/jgo.2022.33.e13
- 1 January 2022
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 33 (2) , e13
Open AccessAn evaluation of prognostic factors, oncologic outcomes, and management for primary and recurrent squamous cell carcinoma of the vulva
Li JY, et al. J Gynecol Oncol. 2021 Nov;33:e13. https://doi.org/10.3802/jgo.2022.33.e13
- Open Access
- 20 December 2021
- Published by Elsevier in Gynecologic Oncology Reports
- Vol. 39, 100913
Clinicopathologic characteristics and oncologic outcomes in adenosarcoma of gynecologic sites
- 20 December 2021
- Published by Elsevier in Gynecologic Oncology Reports
- Vol. 39, 100913
Open AccessClinicopathologic characteristics and oncologic outcomes in adenosarcoma of gynecologic sites
- 1 August 2021
- Published by Elsevier in Gynecologic Oncology
- Vol. 162, S113-S114
Clinicopathologic characteristics and oncologic outcomes in adenosarcoma of gynecologic sites
- 1 August 2021
- Published by Elsevier in Gynecologic Oncology
- Vol. 162, S113-S114
Clinicopathologic characteristics and oncologic outcomes in adenosarcoma of gynecologic sites
- 1 August 2021
- Published by Elsevier in Gynecologic Oncology
- Vol. 162, S186-S187
In vitro and in vivo activity of DHES0815A, an antibody-drug conjugate targeting HER2/neu in uterine serous carcinoma
- 1 August 2021
- Published by Elsevier in Gynecologic Oncology
- Vol. 162, S186-S187
In vitro and in vivo activity of DHES0815A, an antibody-drug conjugate targeting HER2/neu in uterine serous carcinoma
- 1 February 2021
- Published by Elsevier in Journal of Minimally Invasive Gynecology
- Vol. 28 (2) , 176-177
Robotic Low Anterior Resection and Partial Bladder Resection for Management of Locoregional Endometrial Cancer Recurrence
- 1 February 2021
- Published by Elsevier in Journal of Minimally Invasive Gynecology
- Vol. 28 (2) , 176-177
Robotic Low Anterior Resection and Partial Bladder Resection for Management of Locoregional Endometrial Cancer Recurrence
- Open Access
- 1 January 2021
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 32 (6)
Financial toxicity in patients with gynecologic malignancies: a cross sectional study
Zeybek B, et al. J Gynecol Oncol. 2021 Jul;32:e87. https://doi.org/10.3802/jgo.2021.32.e87
- 1 January 2021
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 32 (6)
Open AccessFinancial toxicity in patients with gynecologic malignancies: a cross sectional study
Zeybek B, et al. J Gynecol Oncol. 2021 Jul;32:e87. https://doi.org/10.3802/jgo.2021.32.e87
- Open Access
- 1 November 2020
- Published by Elsevier in Gynecologic Oncology Reports
- Vol. 34, 100673
Robotic radical trachelectomy with an abdominally placed vaginal cerclage for containment of early stage cervical cancer
- 1 November 2020
- Published by Elsevier in Gynecologic Oncology Reports
- Vol. 34, 100673
Open AccessRobotic radical trachelectomy with an abdominally placed vaginal cerclage for containment of early stage cervical cancer